Mackay jumps Pfizer ship to head AZ R&D

Pfizer this morning announced a big change at the top of its R&D empire as it continues to meld its development program with Wyeth's. Mikael Dolsten  (photo), M.D., PhD., the former head of Wyeth's R&D, has been named the global chief of Pfizer research and development while Martin Mackay (photo) leaves Pfizer to take the same job at AstraZeneca. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.